The systematic review included 15 studies that compared GLP-1 agonist and basal insulin combination therapy with other antidiabetic drugs in 4,348 adults with type 2 diabetes
Understanding this connection requires examining both the weight loss mechanism and the neurological effects of these medications
1,2 Preclinical studies indicate that GLP-1RAs can modulate dopamine signaling, reducing drug-seeking behaviors and substance intake
In obese patients, the goal of body mass loss is to decrease fat mass because it is the cause of a pro-inflammatory environment responsible for numerous clinical complications associated with the pathology
Si se expone al calor o la luz
It helps maintain mitochondrial membrane potential and prevent the release of pro-apoptotic factors from mitochondria, thereby preserving cell viability (Pang, 2015)